Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionMorgan Stanley
Latest Disclosed Ownership606,348 shares
Latest Disclosed Value $ 138,690,183
Morgan Stanley reports 1.88% decrease in ownership of ASND / Ascendis Pharma A/S

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 606,348 shares of Ascendis Pharma A/S (US:ASND) valued at $138,689,978 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 617,968 shares of Ascendis Pharma A/S. This represents a change in shares of -1.88% during the quarter. The current value of the position is $131,450,183 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 606,348 -11,620 -1.88 138,690 5.25 0.0084
2026-05-27 2025-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 617,968 211,207 51.92 131,776 62.95 0.0079
2026-02-13 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 617,968 211,207 131,776 0.0079
2026-05-27 2025-09-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 406,761 151,976 59.65 80,868 83.89 0.0049
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 406,761 151,976 80,868 0.0049
2025-08-15 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 254,785 -1,648,746 -86.62 43,976 -85.18 0.0029
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,903,531 1,077,770 130.52 296,684 160.98 0.0212
2025-05-15 2024-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 825,761 513,273 164.25 113,683 143.65 0.0080
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 825,761 513,273 113,683 0.0080
2025-05-14 2024-09-30 13F/A-2 ASCENDIS PHARMA A SPONSORED ADR 04351P101 312,488 145,519 87.15 46,658 104.90 0.0034
2025-02-14 2024-09-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 312,488 145,519 46,658 0.0034
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 312,488 145,519 46,658 0.0004
2025-05-14 2024-06-30 13F/A-2 ASCENDIS PHARMA A SPONSORED ADR 04351P101 166,969 14,917 9.81 22,771 -0.93 0.0018
2024-10-17 2024-06-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 166,969 14,917 22,771 0.0018
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 166,969 14,917 22,771 0.0018
2024-10-17 2024-03-31 13F/A-2 ASCENDIS PHARMA A SPONSORED ADR 04351P101 152,052 30,176 24.76 22,986 49.74 0.0018
2024-08-16 2024-03-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 152,052 30,176 22,986 0.0018
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 152,052 30,176 22,986 0.0018
2024-08-16 2023-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 121,876 45,194 58.94 15,350 113.79 0.0014
2024-02-13 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 121,876 45,194 15,350 0.0014
2023-11-15 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 76,682 -7,420 -8.82 7,181 -4.34 0.0007
2023-08-14 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 84,102 -49,116 -36.87 7,506 -47.45 0.0007
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 133,218 50,275 60.61 14,284 41.01 0.0015
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 82,943 -88,514 -51.62 10,130 -42.79 0.0012
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 171,457 -24,890 -12.68 17,705 -3.00 0.0024
2022-10-27 2022-06-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 196,347 89,668 84.05 18,253 45.79 0.0024
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 196,347 89,668 18,253 0.0005
2022-10-27 2022-03-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 106,679 43,112 67.82 12,520 46.42 0.0017
2022-05-13 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 106,679 43,112 12,520 0.0017
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 63,567 5,439 9.36 8,551 -7.71 0.0011
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 58,128 -20,222 -25.81 9,265 -10.11 0.0012
2021-08-23 2021-06-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 78,350 50,343 179.75 10,307 185.51 0.0014
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 78,350 50,343 10,307 0.0003
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 28,007 -22,653 -44.72 3,610 -57.28 0.0005
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 50,660 47,606 1,558.81 8,450 1,694.06 0.0013
2020-11-13 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 3,054 200 7.01 471 11.61 0.0001
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,854 520 22.28 422 60.46 0.0001
2020-05-26 2020-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,334 -4,508 -65.89 263 -72.37 0.0001
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,334 -4,508 263 20.2039
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,842 3,845 128.29 952 229.41 0.0002
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,997 1,529 104.16 289 71.01 0.0001
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,468 -2,507 -63.07 169 -63.89 0.0000
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 3,975 -26,588 -86.99 468 -75.56 0.0001
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 30,563 -16,537 -35.11 1,915 -42.63 0.0006
2019-04-23 2018-09-30 13F/A-2 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 47,100 16,434 53.59 3,338 63.63 0.0008
2018-11-20 2018-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 47,100 0 3,338 0.0008
2018-11-14 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 47,100 16,434 3,338
2019-04-23 2018-06-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 30,666 16,963 123.79 2,040 127.68 0.0006
2018-08-14 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 30,666 16,963 2,040
2019-04-23 2018-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 13,703 -49,989 -78.49 896 -64.89 0.0002
2018-05-14 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 13,703 -49,989 896
2019-04-23 2017-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 63,692 -3,640 -5.41 2,552 4.55 0.0007
2018-02-14 2017-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 63,692 -3,640 2,552
2017-11-14 2017-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 67,332 26,502 64.91 2,441 115.26 0.0007
2017-08-11 2017-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 40,830 30,594 298.89 1,134 295.12 0.0003
2017-05-22 2017-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 10,236 9,574 1,446.22 287 2,107.69 0.0001
2017-05-12 2017-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 10,236 287
2017-02-22 2016-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 662 662 13 0.0000
2017-02-13 2016-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 662 13
2016-08-12 2016-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -25,759 -100.00 0 -100.00
2016-05-12 2016-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 25,759 22,908 803.51 478 819.23 0.0002
2016-02-09 2015-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,851 2,332 449.33 52 477.78 0.0000
2016-02-08 2015-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 519 -1,141 -68.73 9 -68.97 0.0000
2015-11-09 2015-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 519 9
2015-08-12 2015-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,660 -3,590 -68.38 29 -68.13 0.0000
2015-05-14 2015-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 5,250 5,250 91 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.